PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
StakeholdersAdjunct IndustriesCreative & Design ServicesMarketing, Communications & PR
6 Organisations

Marketing, Communications & PR

Marketing, PR, and communications firms managing public perception and media strategy for psychedelic organisations.

Organisations
6

All Organisations

5W Public Relations (5WPR)

Global PR agency with documented agency-of-record work for Filament Health in the psychedelic therapeutics ecosystem.

View Profile

CURA Communications

Specialist communications firm focused on neuropsychiatry, mental health, and psychedelics, with public partner/client logos across research, biotech, and nonprofit stakeholders.

View Profile

Durée & Company

US public-relations and marketing agency with a dedicated psychedelics-focused practice and messaging for regulated neuro-wellness brands.

View Profile

KCSA Strategic Communications

Strategic communications and investor-relations firm with documented client mandates in the clinical psychedelics sector.

View Profile

NisonCo PR

PR and digital-communications agency with dedicated psychedelics-focused public-relations and content services for companies and nonprofits.

View Profile

Quaintise

Boutique digital and creative agency with case-study evidence for ketamine-clinic growth campaigns and conversion-focused patient acquisition work.

View Profile

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.